Mammography Market By Product Type (Film-Screen Systems; Digital Systems; 3D Systems; Analog Systems; Others); By Technology (CAD Mammography; Breast Tomosynthesis; Digital Mammography); By Modality (Portable; Non-Portable); By End User (Hospitals; Diagnostic Imaging Centers; Specialty Clinics; Ambulatory Surgical Centers; Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Mammography Market Size & Overview

The Global Mammography Market is estimated to be valued at USD 2.8 billion and is projected to surpass USD 4.3 billion by 2030, growing at a CAGR of 10.1% during the forecast period. The growth is driven by the rising global burden of breast cancer and increasing public health initiatives for early screening and diagnosis.

 

According to the WHO, breast cancer is the most common cancer globally, with 2.3 Mn new cases diagnosed in 2022 alone. It is also the leading cause of cancer-related deaths among women, especially in low and middle income countries where access to screening & treatment remains limited. The CDC reports that in the United States, about 240,000 women are diagnosed with breast cancer each year, and over 42,000 women die from the disease annually.

Mammography remains the gold standard for breast cancer screening, especially among women aged 50–74 years, as recommended by the U.S. Preventive Services Task Force (USPSTF). The shift from traditional film-screen to digital mammography & 3D breast tomosynthesis has significantly improved early detection rates, image quality & workflow efficiency. The FDA continues to play a key role in regulating mammography systems and has approved several AI-integrated technologies aimed at enhancing detection accuracy and reducing diagnostic delays.

 

Government-funded screening programs, awareness campaigns, and mobile mammography units are further expanding access to underserved regions. However, disparities in screening uptake, equipment costs & the need for skilled radiologists remain key challenges. Still, the growing adoption of AI-driven tools & mobile screening solutions presents major opportunities for improving global breast cancer outcomes.

 

Mammography Market Dynamics:

Market Drivers

Rising Global Incidence of Breast Cancer

Breast cancer ranks as the most prevalent cancer globally & remains a significant contributor to cancer-related deaths worldwide. In 2022, breast cancer affected 2.3 million women worldwide, resulting in 670,000 deaths globally. The incidence of breast cancer is higher in high-income countries, with a rate of 571 per 100,000, compared to 95 per 10,000 in low-income countries, highlighting its connection to globalization. A Nature Medicine study highlights that approximately 1 in 20 women globally face a lifetime risk of being diagnosed with breast cancer. Projections suggest that, if current trends persist, annual breast cancer cases could rise to 3.2 million and related fatalities could reach 1.1 million by 2050. The growing burden of breast cancer is significantly boosting the demand for early detection methods like mammography, which remains the gold standard for screening & diagnosis.

Government-Led Screening Programs & Public Awareness Initiatives

Many countries have implemented national screening programs to improve early breast cancer detection. The WHO Global Breast Cancer Initiative (GBCI) seeks to reduce global breast cancer mortality rates by 2.5% each year, with the potential to save 2.5 million lives over the period from 2020 to 2040. This includes a 25% reduction in deaths by 2030 & 40% by 2040 for women under 70. The strategy focuses on three key areas: promoting early detection, ensuring timely diagnosis & providing comprehensive breast cancer care. The U.S. Preventive Services Task Force (USPSTF) recommends biennial screening mammography for women aged 50 - 74 years, contributing to widespread adoption.

 

Market Restraints

High Equipment & Maintenance Costs

Digital mammography and especially 3D breast tomosynthesis (DBT) systems can cost between $150,000 - $400,000 per unit, excluding installation & software upgrades. According to a 2022 survey by Breastcancer.org involving 1,437 U.S. residents diagnosed with breast cancer within the past decade, 47% reported that out-of-pocket expenses related to their treatment posed a significant or catastrophic financial burden. Additionally, 37% had to cut back on basic necessities to afford their treatment costs. These high costs pose a barrier to adoption in low-income & rural settings, where healthcare facilities often lack infrastructure & funding for advanced imaging systems.

Limited Access & Low Screening Rates in Developing Regions

Despite the benefits, screening coverage remains low in several developing countries due to lack of trained radiologists, poor awareness, & cultural barriers. A trend analysis conducted by the American Cancer Society and GLOBOCAN reveals a rise in both the incidence & mortality rates of breast cancer in various South American and Asian countries. Breast cancer screening coverage is below 20% in many African and South Asian countries, compared to over 70% in high-income regions, leading to late-stage diagnoses & poorer outcomes. Efforts to control & prevent breast cancer in LMICs should prioritize developing cost-effective & targeted solutions to address the unique challenges of each sub-region.

 

Market Opportunities

Expansion of Artificial Intelligence (AI) in Breast Imaging

AI is playing an increasingly important role in mammography by enhancing image interpretation, reducing false positives/negatives, and improving radiologist workflow. A 2020 study published in Nature analyzed over 91,000 mammograms from women in the US and the UK, revealing that the use of an AI system reduced false positive rates by nearly 6% in the US and 1.2% in the UK. AI tools such as computer-aided detection (CAD) & deep learning algorithms are being integrated into digital mammography systems. According to a study published in Radiology: Artificial Intelligence, the AI tool iBRISK (intelligent-augmented breast cancer risk calculator) demonstrated the ability to accurately predict whether abnormal tissue identified by doctors was more likely to be benign or malignant. FDA-approved AI tools are already in clinical use for automated breast density assessment & lesion detection.

Growth in Mobile & Point-of-Care Mammography Units

Mobile mammography vans & portable systems are bridging the gap in rural & underserved areas. There are more than 2000 mobile health clinics (MHCs) operating in the US. Stony Brook's MMU has been recognized as an essential initiative, encouraging mammography among marginalized women who seek nonurgent care in the emergency department. These units enable on-site screening in remote villages, urban slums, and workplace health camps, particularly in countries like India, Brazil & South Africa. The Mobile Mammography Units has removed numerous healthcare barriers faced by underserved populations, such as lack of transportation, absence of health insurance, and language barriers, among others. The increased focus on outreach-based cancer screening is expected to drive adoption of compact, battery-operated & easy to deploy mammography systems.

 

Mammography Market Segmentation: A Comprehensive Overview

By Product Type

• Film-Screen Systems

• Digital Systems

• 3D Systems

• Analog Systems

• Others

 

By Technology

• CAD Mammography

• Breast Tomosynthesis

• Digital Mammography

 

By Modality

• Portable

• Non-Portable

 

By End User

• Hospitals

• Diagnostic Imaging Centers

• Specialty Clinics

• Ambulatory Surgical Centers

• Others

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Mammography Market Segment Analysis: Growth Trends Across Categories

By Product Type:

Leading Segment: Digital Systems

Digital systems dominate the mammography market, holding approximately 45% of the total market share. More than 99% of certified mammography facilities in the United States utilize some form of digital equipment. The growing demand for high-resolution imaging & the increasing prevalence of breast cancer screening are key drivers of digital system adoption.

Fastest-Growing Segment: 3D Systems

The fastest-growing segment in the mammography market is 3D systems, which are projected to grow at a CAGR of 12%. 3D mammography, also known as breast tomosynthesis, allows for the capture of detailed, layered images of the breast tissue, improving the detection of cancers, especially in dense breasts. The technology’s enhanced diagnostic accuracy is driving its rapid adoption in both routine screenings & diagnostic settings.

 

By Technology:

Leading Segment: Digital Mammography

Digital mammography holds the largest market share within the technology segment, contributing approximately 40% to the total market. Digital mammography surpasses film-based methods with lower radiation doses, AI-driven diagnostic improvements, cost efficiency, eco-friendly technology & remote access to expert opinions

Fastest-Growing Segment: Breast Tomosynthesis

Breast tomosynthesis, or 3D mammography, is the fastest-growing technology in the market, with a CAGR of 10%. This technology is highly effective in reducing false positives & negatives, providing greater clarity for radiologists & improving patient outcomes by detecting cancers at earlier stages, particularly in women with dense breast tissue.

 

By Modality:

Leading Segment: Non-Portable

Non-portable systems hold the largest share in the mammography market, accounting for about 70% of the total market. These systems are typically installed in hospitals & diagnostic imaging centers, where high throughput and advanced imaging capabilities are required for breast cancer screening and diagnosis. The demand for non-portable systems remains high due to their superior image quality and integration with other diagnostic equipment.

Fastest-Growing Segment: Portable

Portable mammography systems are the fastest-growing segment, with a CAGR of 11.5%. Portable systems are increasingly used in rural areas, remote locations & mobile clinics, where access to traditional imaging facilities may be limited. The ability to conduct screenings in underserved areas is driving the adoption of portable systems, improving accessibility to breast cancer diagnostics.

 

By End User:

Leading Segment: Hospitals

Hospitals are the largest end-user of mammography systems, making up approximately 50% of the market share. Hospitals play a central role in breast cancer diagnosis and treatment, with mammography being a routine screening method for detecting breast abnormalities. Hospitals' comprehensive healthcare facilities, including radiology departments, are key drivers of this segment’s dominance.

Fastest-Growing Segment: Ambulatory Surgical Centers (ASCs)

ASCs represent the fastest-growing end-user segment, with a CAGR of 9%. The rise of ASCs is driven by their cost-effectiveness, convenience for patients & ability to provide specialized diagnostic services like mammography in a more outpatient-oriented setting. ASCs are increasingly adopting advanced mammography systems for breast cancer screening & diagnostics.

 

By Region:

Leading Region: North America

North America holds the largest market share in the mammography market, accounting for approximately 40% of the global market. In the United States, breast cancer is the most frequently diagnosed cancer among women, accounting for 32% of new cancer cases annually. There are currently more than 4 Mn women with a history of breast cancer in the U.S. According to the latest CDC data, breast cancer is the second most common cancer among women in the United States, following skin cancer. Women face an average lifetime risk of 13% for developing breast cancer. The region's strong healthcare infrastructure, high adoption of advanced technologies & government initiatives such as the Affordable Care Act, which expanded access to breast cancer screening, contribute to its dominance. The U.S., in particular, has a high demand for mammography services due to a high incidence of breast cancer & routine screening recommendations.

 

Fastest-Growing Region: Asia-Pacific

APAC is the fastest-growing region for the mammography market, with a CAGR of 9.5%.  The rising prevalence of breast cancer, increasing healthcare investments & growing awareness about early detection are key factors driving this growth. According to the WHO, Asia currently accounts for 45% of all global breast cancer cases. Countries like China, India & Japan are witnessing increasing adoption of mammography systems to address the rising burden of breast cancer. Biopharma companies launched nearly 900 breast cancer trials between 2019-2020, with approximately 40% taking place in the APAC region.

 

Incidence, mortality and 5-year prevalence of Breast cancer in a selection of locations

	New Cases		Deaths		5-year Prevalence
Country	Number	ASR*	Number	ASR	Number	Proportions
Australia	19,617	96.0	3,132	11.7	84,199	657.7
Greater China	416,371	39.1	117,174	10.0	1,390,095	197.0
India	178,361	25.8	90,408	13.3	459,271	69.3
Malaysia	8,418	49.3	3,503	20.7	29,453	187.2
New Zealand	3,660	93.0	660	14.1	15,403	628.2
Philippines	27,163	52.7	9,926	19.3	85,206	156.2
Singapore	3,662	77.9	921	17.8	15,306	549.0
South Korea	25,814	64.2	3,009	6.4	86,672	338.5
Thailand	22,158	37.8	8,266	12.7	76,440	213.3
United States	253,465	90.3	42,617	12.4	1,070,703	640.3

 

*Age standardized rate per 100,000

**Proportions per 100,000

 

Key Players in the Mammography Market

• GE Healthcare

• Philips Healthcare

• Hologic, Inc.

• Siemens Healthineers

• Canon Medical Systems Corporation

• Fujifilm Medical Systems

• Shimadzu Corporation

• Carestream Health

• Konica Minolta, Inc.

• Ziehm Imaging

 

Mammography Market Report Coverage

Report Attribute	Details
Forecast Period	2024 – 2032
Market Size Value in 2024	USD 2.8 Billion
Revenue Forecast in 2030	USD 4.3 Billion
Overall Growth Rate	CAGR of 10.1% (2024 – 2030)
Base Year for Estimation	2023
Historical Data	2017 – 2021
Unit	USD Billion, CAGR (2024 – 2030)
Segmentation	By Product Type, By Technology, By Modality, By End User, By Geography
By Product Type	Film-Screen Systems, Digital Systems, 3D Systems, Analog Systems, Others
By Technology	CAD Mammography, Breast Tomosynthesis, Digital Mammography
By Modality	Portable, Non-Portable
By End User	Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Ambulatory Surgical Centers, Others
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, Germany, China, India, etc.
Market Drivers	Rising prevalence of breast cancer, technological advancements in imaging, growing awareness about early detection
Pricing and Purchase Options	Customized options available

 

Future Outlook

The future of the global mammography market looks promising, with strong momentum towards innovation, accessibility, and integration into broader public health frameworks. As breast cancer continues to be a leading cause of cancer-related mortality among women, the demand for earlier & more accurate diagnostic tools is expected to intensify.

Advances in 3D breast tomosynthesis, contrast-enhanced mammography, & AI-powered image analysis will play a transformative role in enhancing diagnostic precision & reducing false positives. The integration of artificial intelligence is particularly expected to address the global shortage of radiologists & streamline workflow in high-volume screening settings.

Simultaneously, governments and global health organizations are likely to expand national screening programs, particularly in LMICs where breast cancer is often diagnosed at late stages. The adoption of mobile mammography units, battery-operated digital systems & cloud-based data sharing platforms will help extend diagnostic services to rural & underserved populations. Moreover, increasing health awareness, rising insurance coverage, and growing healthcare infrastructure in emerging economies are expected to accelerate market penetration.

By 2030, the mammography market will not only be driven by high-income countries but also see substantial growth across Asia-Pacific, Latin America & parts of Africa, supported by public-private collaborations and innovation in cost-effective technologies. With continued emphasis on early detection & patient-centric care, mammography is set to remain a cornerstone of breast cancer control strategies worldwide.